Form 8-K - Current report:
SEC Accession No. 0000950170-24-061164
Filing Date
2024-05-16
Accepted
2024-05-16 17:00:12
Documents
11
Period of Report
2024-05-15
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K mnkd-20240515.htm   iXBRL 8-K 69610
  Complete submission text file 0000950170-24-061164.txt   180648

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT mnkd-20240515.xsd EX-101.SCH 23907
14 EXTRACTED XBRL INSTANCE DOCUMENT mnkd-20240515_htm.xml XML 4516
Mailing Address 1 CASPER STREET DANBURY CT 06810
Business Address 1 CASPER STREET DANBURY CT 06810 818-661-5000
MANNKIND CORP (Filer) CIK: 0000899460 (see all company filings)

EIN.: 133607736 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50865 | Film No.: 24956506
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)